Drug Development

Potential new therapy for childhood brain cancer is effective in infiltrating, killing tumor cells in preclinical models in mice

Patient-derived xenograft models enable researchers to explore novel therapies and diagnostic tools within the context of specific mutational signatures, treatment histories, and more

New CLIA-certified lab ensures seamless transition from early assay development and testing to full companion diagnostics commercialization

New article outlines best practices, novel statistical methods, and suggestions for improving benefit-risk assessments in clinical trials

The NIH-supported clinical trial could lead to the first effective treatment for ACDC disease

Automation, AI, and digital health technologies can help make clinical trials more efficient, inclusive, and impactful

Per the first author, "the reactome could change the way we think about organic chemistry."

Explore the transformative impact of artificial intelligence on drug development and its role in the future of pharmaceutical innovation

Some 42 percent of patients treated with sparsentan showed reduced proteinuria